Granulosa cell tumors (GCT) constitute only ~5% of ovarian neoplasms yet have significant consequences, as up to 80% women with recurrent GCT will die the disease. This study investigated effectiveness procaspase-activating compound 1 (PAC-1), an activator procaspase-3, in treating adult (AGCT) combination selected apoptosis-inducing agents. Sensitivity AGCT line KGN these drugs, alone or PAC-1...